Elinx Stock

Elinx ROE

The Return on Equity (ROE) of Elinx (ELNX) as of Aug 22, 2026 is 19.75 %.

ROE

19.75 %

Last updated:

In 2026, Elinx's return on equity (ROE) was 19.75 %, a % increase from the - ROE in the previous year.

Access this data via the Eulerpool API

Elinx Stock analysis

What does Elinx do? Aperture Health Inc. is a globally operating company in the healthcare industry based in San Francisco, California. The company was founded in 2014 by a group of healthcare experts with the goal of revolutionizing healthcare. Since its inception, the company has experienced rapid growth and is now a major player in the healthcare market. Aperture Health Inc.'s business model is based on the development and sale of innovative products and services in the healthcare sector. The company operates in multiple business fields, all aiming to improve healthcare. This includes digital health, clinical diagnostic tests, healthcare, and health insurance. In the field of digital health, the company offers a wide range of solutions aimed at simplifying healthcare management. These solutions include mobile health applications that allow users to monitor and track their health data. The company is also working on the development of personalized medical devices and wearables that help diagnose and treat various health issues. Aperture Health Inc. is also involved in the development and manufacturing of clinical diagnostic tests. The company has developed a wide range of diagnostic tests for diseases such as cancer, diabetes, and HIV. These tests are fast and easy to perform and provide accurate results. In the area of healthcare, the company provides a wide range of services aimed at improving the quality of healthcare. These services include access to specialized medical professionals, assistance in organizing doctor visits, and prescription of medications. Aperture Health Inc. works closely with hospitals and medical facilities to provide seamless and high-quality healthcare. Aperture Health Inc. also offers innovative health insurance tailored to the needs of customers. These insurances combine a wide range of health insurance options that meet the customers' needs with an intelligent health management system that allows policyholders to monitor and improve their health. The company is also engaged in research and development of new treatment methods. Aperture Health Inc. collaborates closely with medical research institutions and professionals to develop new and innovative treatment methods that aim to improve healthcare globally. In summary, Aperture Health Inc. is a company that aims to revolutionize healthcare worldwide. The company offers innovative products and services aimed at improving people's health and increasing their quality of life. With a wide range of solutions in various business fields, Aperture Health Inc. has become a major player in the healthcare industry and will continue to play an important role in the future. Elinx is one of the most popular companies on Eulerpool.

ROE Details

Decoding Elinx's Return on Equity (ROE)

Elinx's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Elinx's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Elinx's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Elinx’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Elinx stock

Return on Equity (ROE) of Elinx is 19.75 % in 2026.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Elinx since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Elinx with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

Profitability — Elinx

All Key Metrics — Elinx